Sign In
Buy GERN
$1.16
-0.0100 (-0.85%)
At Close: Jun 03, 2026
Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants
08:30pm, Wednesday, 27'th May 2020
Geron Corporation (GERN), a late-stage clinical biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of 107,049,375 shares of its common stoc
Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants
12:00am, Wednesday, 27'th May 2020Alnylam's Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:ALNY)
07:44am, Sunday, 24'th May 2020
Alnylam announces positive ONPATTRO trial data. Geron to start phase 3 trial in Myelofibrosis. Atara reports successful early stage data.
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
12:00am, Sunday, 24'th May 2020
Biotech stocks closed the week ended May 22 higher, with stray clinical readouts and COVID-19 drug- and vaccine-related news moving stocks in the sector.
Surface Oncology Inc (...
Stocks close steady but post gains for the week ahead of U.S. Memorial Day holiday
08:25pm, Friday, 22'nd May 2020
U.S. stock benchmarks end up for the week despite rising Sino-American tensions and a holiday that could test the bounds of business reopening efforts after...
Mid-Day Market Update: LiveRamp Surges Following Q4 Results; Syndax Pharmaceuticals Shares Plummet
04:39pm, Friday, 22'nd May 2020P/E Ratio Insights for Geron
03:11pm, Friday, 22'nd May 2020
In the current market session, Geron Inc. (NASDAQ:GERN) is trading at $1.52, after a 22.19% decrease. However, over the past month, the stock increased by 31.47%, and in the past year, by 0.33%. Share
Geron's stock tumbles after large share offering prices at 34% discount
12:13pm, Friday, 22'nd May 2020
Shares of Geron Corp. plunged 26% in premarket trading Friday, after the biopharmaceutical company's large public offering of stock priced at a 34% discount. The stock offering comes about a week aft
20 Healthcare Stocks Moving In Friday's Pre-Market Session
11:47am, Friday, 22'nd May 2020Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants
11:15am, Friday, 22'nd May 2020
Geron Corporation (GERN), a late-stage clinical biopharmaceutical company, today announced the pricing of its previously announced underwritten public offering of 107,049,375 shares of its common stoc
The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray
12:00am, Friday, 22'nd May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 21)
ADC Therapeutics SA (NYSE:...
Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants
08:03pm, Thursday, 21'st May 2020
Geron Corporation (GERN), a late-stage clinical biopharmaceutical company, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of
Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other Updates
08:01pm, Thursday, 21'st May 2020
Geron Corporation (GERN), a late-stage clinical biopharmaceutical company, today announced plans for a Phase 3 clinical trial in MF patients who are refractory to treatment with a janus kinase (JAK) i
